Outset Medical, Inc.
NASDAQ:OMMedical - Devices
+$0.73 today
- Market cap
- $57.31M
- Beta
- 1.94
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$4.07
Volume 0.05M
Average 0.16M
OM Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Outset Medical, Inc.NASDAQ: OM
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments rises 11.6% from a year ago
Short-term investments stood at $126.14M at the end of Q1 FY2026, up 11.6% from a year earlier and down 5.8% from the prior quarter. Over 3 fiscal years it compounded at -14.5% a year.
Context
- Short-term investments amounted to 50.6% of total assets at the end of Q1 FY2026, up 13.0 pp from a year earlier.
- Short-term investments increased in 1 of the last 3 fiscal years.
What to watch
Whether short-term investments keeps rising in the next quarterly balance sheet after a +11.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 133.94M USD
- Year-over-year change
- +286.3%
- 4-year CAGR
- -3.9%
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 133.94M | +286.3% |
| FY2024 | 2024-12-31 | 34.67M | -74.3% |
| FY2023 | 2023-12-31 | 134.82M | -37.1% |
| FY2022 | 2022-12-31 | 214.28M | +36.4% |
| FY2021 | 2021-12-31 | 157.14M | — |
Short-term Investments vs competitors
How OM compares with its peers on the latest reported figures
- OM's Mar 2026 short-term investments of $126.14M is the 2nd highest of the 10 companies compared; the peer median is $10.46M.
- Its year-over-year change of +11.6% is the 3rd highest of 6, against a peer median of -66.9%.
- Short-term investments amounts to 50.6% of total assets for OM, versus a peer median of 6.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $216.96M | +29.7% | +71.1% | 52.8% | |
| Mar 2026 | $126.14M | +11.6% | -14.5% | 50.6% | |
| Mar 2026 | $97.05M | +357.9% | — | 60.5% | |
| Mar 2026 | $63.08M | -66.9% | — | 17.2% | |
| Mar 2026 | $17.06M | — | — | 6.0% | |
| Dec 2025 | $10.46M | -69.1% | -35.6% | 6.4% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding OM) | $10.46M | -66.9% | +17.8% | 6.0% | |
Competitors are the stored peer set for OM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 182.35M | 73.22M | 68.51M | 124.01M | 35.01M |
| Short-term Investments | 157.14M | 214.28M | 134.82M | 34.67M | 133.94M |
| Net Receivables | 25.6M | 28.07M | 32.98M | 35.62M | 28.33M |
| Inventory | 39.19M | 51.48M | 49.22M | 59.39M | 47.61M |
| Other Current Assets | 5.53M | 6.6M | 5.7M | 4.53M | 6M |
| Total Current Assets | 409.8M | 373.65M | 291.22M | 258.22M | 250.88M |
| Property, Plant & Equipment (Net) | 20.2M | 21.99M | 18.65M | 12.07M | 9.47M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 33.31M | 3.31M | 3.33M | 0 | 3.83M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 156K | 1.17M | 3.93M | 5.5M | 317K |
| Total Non-current Assets | 53.66M | 26.47M | 22.58M | 17.57M | 13.61M |
| Total Assets | 463.46M | 400.12M | 313.8M | 275.8M | 264.5M |
| Account Payables | 1.76M | 603K | 5.83M | 3.86M | 554K |
| Short-term Debt | 0 | 0 | 0 | 1.8M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 6.34M | 8.66M | 11.73M | 12.75M | 13.8M |
| Other Current Liabilities | 17.49M | 19.85M | 24.77M | 25.17M | 5.44M |
| Total Current Liabilities | 51.7M | 51.95M | 55.32M | 45.38M | 37.63M |
| Long-term Debt | 29.76M | 96.34M | 130.11M | 197.38M | 96.24M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 312K | 151K | 101K | 844K | 406K |
| Other Non-current Liabilities | 721K | 113K | 896K | 2.7M | 406K |
| Total Non-current Liabilities | 37.69M | 102.18M | 135.59M | 203.6M | 99.91M |
| Total Liabilities | 89.38M | 154.13M | 190.92M | 248.98M | 137.54M |
| Common Stock | 47K | 48K | 50K | 53K | 18K |
| Retained Earnings | (625.99M) | (788.95M) | (961.75M) | (1.09B) | (1.17B) |
| Accumulated OCI | (184K) | (564K) | 68K | 42K | 172K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 374.08M | 245.99M | 122.89M | 26.82M | 126.95M |
| Total Debt | 37.81M | 103.23M | 136.19M | 201.86M | 101.25M |
| Net Debt | (144.54M) | 30.01M | 67.68M | 77.84M | 66.24M |
Outset Medical, Inc.
NASDAQ:OM
Intrinsic Alpha fair value
Locked
Current Price
$3.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.